封面
市场调查报告书
商品编码
1622108

In Vitro ADME检验服务的全球市场规模:各类型,各用途,各地区,范围及预测

Global In Vitro ADME Testing Services Market Size By Type (Small Molecules, Biologics), By Application (Blood To Plasma Ratio, Metabolic Stability), By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

体外 ADME 测试服务市场规模及预测

体外 ADME 测试服务市场规模预计 2024 年为 63.1 亿美元,2024 年至 2031 年复合年增长率为 9.29%,预计到 2031 年将达到 128.5 亿美元。市场发展得到了针对多种疾病开发新药的加强研究力度的支持。该研究报告对全球体外 ADME 测试服务市场进行了全面评估。它对关键细分市场、趋势、市场驱动因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球体外 ADME 测试服务市场定义

ADME是一个缩写,指物质和药物在人体内的吸收、分布、代谢和排泄,用于药物动力学和药理学。此外,了解影响候选化合物功效和安全性的主要理化特征和结构基序在药物研究的早期阶段至关重要。在体外,ADME 用于确定吸收、分布、代谢和排泄特性。 ADME 测试对于了解新陈代谢和可能的药物交互作用至关重要。

此外,对于体外感染,药物动力学模型可以帮助研究人员更了解抗生素的药效特性。当与动物和人类药效学研究结合使用时,它可以为优化给药方案提供有用的数据。体外模型可用于表征药物对细菌族群的影响或取得数据以进行更多分析研究,例如假设检定。分析研究设计揭示了与预期结果最密切相关的药效参数和大小。

全球体外 ADME 测试服务市场概览

由于药物开发研究资金增加等因素,体外 ADME 测试服务的全球市场正在成长。加强研究力度开发针对多种疾病的新药有助于市场扩张。此外,随着慢性、传染性和遗传性疾病数量的增加,对有效治疗的需求也在增加,从而推动了 ADME 检测服务的使用。

此外,与使用动物相比,基于培养的生产的简单性使得体外方法经常成为製药业大规模生产的选择方法。抑制全球体外 ADME 检测服务市场成长的因素包括小鼠腹水法(需要使用小鼠并定期观察)和体内 MAb 测试(需要使用小鼠进行各种小鼠蛋白质等)。需要净化的事实。

目录

第1章 In Vitro ADME检验服务的全球市场:简介

  • 市场概要
  • 调查范围
  • 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

  • 资料探勘
  • 验证
  • 一次采访
  • 资料来源一览

第4章 In Vitro ADME检验服务的全球市场展望

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力分析
  • 价值链分析

第5章 In Vitro ADME检验服务的全球市场:各类型

  • 概要
  • 低分子
  • 生技药品

第6章 In Vitro ADME检验服务的全球市场:各用途

  • 概要
  • 血浆蛋白质结合
  • 血液/血浆比
  • 代谢稳定性
  • shitokuromu酵素诱导/阻碍

第7章 In Vitro ADME检验服务的全球市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区
    • 南美
    • 中东·非洲

第8章 In Vitro ADME检验服务的全球市场:竞争情形

  • 概要
  • 企业的市场排行榜
  • 主要的发展策略

第9章 企业简介

  • Pharmaceutical Product Development
  • Pharmaron
  • Albany Molecular Research
  • Charles River Laboratories
  • Galapagos
  • EnvisionTEC
  • Tecan Group

第10章 附录

  • 相关调查
简介目录
Product Code: 15383

In Vitro ADME Testing Services Market Size And Forecast

In Vitro ADME Testing Services Market size was valued at USD 6.31 Billion in 2024 and is projected to reach USD 12.85 Billion by 2031, growing at a CAGR of 9.29% from 2024 to 2031. The market's expansion is being aided by increased research endeavors to develop novel drugs for several illnesses. The Global In Vitro ADME Testing Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global In Vitro ADME Testing Services Market Definition

The abbreviation ADME, which stands for absorption, distribution, metabolism, and elimination of substances and medications in the human body, is used in pharmacokinetics and pharmacology. Furthermore, Understanding the main physicochemical features and structural motifs that influence a compound candidate's effectiveness and safety profile is critical in the early phases of drug research. In vitro, ADME is used to determine absorption, distribution, metabolism, and excretion characteristics. ADME tests are essential for understanding metabolism and possible medication interactions.

Additionally, In vitro infection, pharmacokinetic models can help researchers better understand the pharmacodynamic features of antibacterial drugs. They give data to assist in the optimization of medication dosage regimens when used in conjunction with animal and human pharmacodynamic studies. In vitro models can be used to characterize a drug's effect on a bacterial population or to give data for more analytical research, such as hypothesis testing. Analytical study designs reveal the pharmacodynamic parameter that is most closely linked to the desired outcome, as well as its magnitude.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global In Vitro ADME Testing Services Market Overview

Global In Vitro ADME Testing Services Market is growing because of some factors such as Funding for drug development research has been boosted. The market's expansion is being aided by increased research endeavors to develop novel drugs for several illnesses. In addition, as the number of chronic, infectious, and hereditary disorders rises, so does the need for effective treatments, which promotes the use of ADME Testing services.

Moreover, Because of the simplicity of culture for production compared to the use of animals, in vitro methods are frequently the methods of choice for large-scale manufacturing by the pharmaceutical sector. Some factors hampering the growth of the Global In Vitro ADME Testing Services Market are the mouse ascites approach necessitates the use of mice that must be observed regularly, and In vivo MAb can include a variety of mouse proteins and other pollutants, which may necessitate purification.

Global In Vitro ADME Testing Services Market Segmentation Analysis

The Global In Vitro ADME Testing Services Market is Segmented on the basis of Type, Application, And Geography.

In Vitro ADME Testing Services Market, By Type

  • Small Molecules
  • Biologics

Based on the Type, the market is into Small Molecules and Biologics. Small molecules are majorly helpful to the growth of the market because small compounds offer various benefits over biologics. Small molecules, on the other hand, are more likely to cause harmful non-target effects because biologics are very target-specific and their side effects are mostly related to exaggerated pharmacological effects, whereas biologics are very target-specific and their side effects are mostly related to exaggerated pharmacological effects.

In Vitro ADME Testing Services Market, By Application

  • Plasma Protein Binding
  • Blood to Plasma Ratio
  • Metabolic Stability
  • Cytochrome Enzyme Induction / Inhibition
  • Based on Application, the market is segmented into Plasma Protein Binding, Blood to Plasma Ratio, Metabolic Stability, and Cytochrome Enzyme Induction / Inhibition. Plasma protein binding stakes a major share in the expansion of global In vitro ADME testing services owing to plasma protein bindings are used to measure the potency of a drug which is a very important parameter,

In Vitro ADME Testing Services Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global In Vitro ADME Testing Services Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is anticipated to dominate the Global In Vitro ADME Testing Services Market due to the rapid adoption of newer technologies, and the presence of government rules and regulations which benefits able to the growth of the market.

Key Players

  • The "Global In Vitro ADME Testing Services Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Pharmaceutical Product Development, Pharmaron, Albany Molecular Research, Charles River Laboratories, Galapagos, EnvisionTEC, and Tecan Group.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In December 2021, Color Health, a health technology business dedicated to enhancing public health, and Thermo Fisher Scientific, a world leader in serving research, announced a substantial extension of their partnership. In Texas, the ReadyCheckGo COVID-19 testing system is used in K-12 schools.
  • In February 2020, Catalent, Inc. ("Catalent"), the world's leading provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Pharma Solutions, Inc., a wholly-owned subsidiary of Catalent, Inc.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL IN VITRO ADME TESTING SERVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL IN VITRO ADME TESTING SERVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Small Molecules
  • 5.3 Biologics

6 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Plasma Protein Binding
  • 6.3 Blood to Plasma Ratio
  • 6.4 Metabolic Stability
  • 6.5 Cytochrome Enzyme Induction / Inhibition

7 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL IN VITRO ADME TESTING SERVICES MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Pharmaceutical Product Development
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Pharmaron
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Albany Molecular Research
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Charles River Laboratories
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Galapagos
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 EnvisionTEC
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Tecan Group
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments

10 Appendix

  • 10.1 Related Research